Results 151 to 160 of about 47,644 (242)

Risk of osteoporosis and fracture among patients with breast cancer: a systematic review and meta-analysis of cohort studies. [PDF]

Front Oncol
Li K, Qian Y, Cao Y.
europepmc   +1 more source

Use of Metronomic Chemotherapy in Hormone Receptor‐Positive/HER2‐Negative Metastatic Breast Cancer: A Retrospective Multicenter Study

Cancer Medicine, Volume 15, Issue 10, October 2026.
ABSTRACT Purpose The optimal chemotherapy strategy after progression on cyclin‐dependent kinase 4/6 inhibitors (CDK4/6i) in hormone receptor‐positive/human epidermal growth factor receptor 2‐negative (HR+/HER2−) metastatic breast cancer remains a matter of controversy.
Lara Laini, Deborah Cosentini, Marta Laganà, Salvatore Grisanti, Giulia Scartabellati, Gianluca Fogazzi, Salvatore Strazzeri, Vito Amoroso, Greta Schivardi, Rebecca Pedersini, Alfredo Berruti, Antonella Turla   +11 more
wiley   +1 more source

Leveraging endocrine sensitivity in ER-positive DCIS: Neoadjuvant therapy and nonoperative management. [PDF]

Breast
Semba R, Childs S, Saw K, Segara D, Mann GB, Shien T, Birrell S, Horimoto Y, Kutomi G, Lim E.   +9 more
europepmc   +1 more source

Menopausal Stage–Specific Associations of Body Fat Content and Total Body Water With Vasomotor Symptoms

Comprehensive Physiology, Volume 16, Issue 5, October 2026.
Associations of adiposity and total body water with vasomotor symptoms varied according to menopausal stage. Divergent relationships observed across body composition measures suggest that distinct physiological mechanisms may underlie vasomotor symptoms during the menopausal transition and postmenopause.
Katarzyna Górecka, Monika Krzyżanowska
wiley   +1 more source

Late-follicular androgen and estrogen rise associated with clinical pregnancy in IVF/ICSI with granulosa cell studies. [PDF]

Reprod Fertil
Sririwichitchai R, Sitticharoon C, Keadkraichaiwat I, Maikaew P, Chanheng S, Petyim S.   +5 more
europepmc   +1 more source

Computational strategies to address therapeutic resistance in estrogen receptor‐positive breast cancer: A narrative review of molecular docking, molecular dynamics simulations, and emerging therapeutic targets

Clinical and Translational Discovery, Volume 6, Issue 5, October 2026.
Computational drug discovery integrates molecular docking, molecular dynamics simulations, and translational clinical targeting to identify next‐generation therapeutics that overcome endocrine resistance in ER‐positive breast cancer. Combined with multi‐omics, artificial intelligence, and biomarker‐guided precision oncology, these approaches accelerate
Emmanuel Ifeanyi Obeagu, Yaregal Asres
wiley   +1 more source

Aromatase inhibitor-induced psoriasiform dermatitis: A case report and literature review. [PDF]

JAAD Case Rep
Klein BA, Thiagarajan AB, Barr RJ, Halle Brady BR, Min MS.   +4 more
europepmc   +1 more source

Efficacy and related factors of levonorgestrel‐releasing intrauterine system combined with metformin in fertility‐preserving treatment for atypical endometrial hyperplasia and early endometrial cancer: A retrospective cohort study

International Journal of Gynecology &Obstetrics, Volume 175, Issue 1, Page 396-407, October 2026.
Abstract Objective To compare the efficacy of the levonorgestrel‐releasing intrauterine system combined with metformin versus oral progestin combined with metformin in fertility‐preserving treatment for patients with atypical endometrial hyperplasia and early endometrial cancer, and to analyze related factors affecting efficacy.
Pengpeng Gu, Jialu Gao, Yuxin Li, Mei Huang, Xiaoshuang Wang, Xin Zhao   +5 more
wiley   +1 more source

Targeting Estrogen Receptor for Breast Cancer. [PDF]

Curr Issues Mol Biol
Yiannakopoulou E.
europepmc   +1 more source

Hormone therapy (HT) in women with premature ovarian insufficiency or early menopause: Time to think of a new paradigm for healthy aging. A joint FIGO and IMS position paper

International Journal of Gynecology &Obstetrics, Volume 175, Issue 1, Page 26-47, October 2026.
Abstract Premature ovarian insufficiency (POI) and early menopause (EM) affect millions of women worldwide. Compared with normal menopause, they confer a longer duration of estrogen deficiency and are associated not only with a shorter lifespan, but with a reduced healthspan, owing to an increased risk of cardiovascular, skeletal, cognitive and ...
Chiara Benedetto, Suvarna S. Khadilkar, Rossella E. Nappi, Andrea R. Genazzani, Federica Frezet, Laura Cucinella, Hema Divakar, Panagiotis Anagnostis, Nick Panay   +8 more
wiley   +1 more source